Frequently Asked Questions
The market is segmented based on Global Radiosurgery Systems (Neurology Devices) Market, By Device Type (CSF Management Devices, CSF Shunt Devices, CSF Drainage Devices, Interventional Neurology Devices), Neuro-Surgery Devices (Neuro-endoscopes, Stereotactic- Systems, Ultrasonic- Aspirators, Aneurysm Clips), Neuro-stimulation Devices (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Nerve Stimulation), End User (Hospitals, Neurology Clinics, Ambulatory Care Centers, and Others) – Industry Trends and Forecast to 2030.
.
The Global Radiosurgery Systems Neurology Devices Market size was valued at USD 1798.68 USD Million in 2022.
The Global Radiosurgery Systems Neurology Devices Market is projected to grow at a CAGR of 5.11% during the forecast period of 2023 to 2030.
The major players operating in the market include Abbott, Johnson & Johnson Services, Boston Scientific Corporation, Stryker Corporation, Medtronic, Terumo Corporation, Penumbra, MicroPort Scientific Corporation, Merit Medical Systems, W.L. Gore & Associates, B. Braun Melsungen AG, Cook, UreSil, Medikit co., Bayer AG, Acandis GmbH, Biosensors International Group, Integra LifeSciences Corporation, Elekta, C.R. Bard.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
